GALECTIN THERAPEUTICS INC (GALT)

US3632252025 - Common Stock

3.03  -0.22 (-6.77%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-41.07M-38.78M-30.53M-23.47M-13.29M
Depreciation Amortization
N/AN/AN/AN/AN/A
Change In Working Capital
4.68M4.97M3.75M940.00K640.00K
Other non cash items
3.42M2.75M2.47M1.92M1.81M
OPERATING CASH FLOW
-32.97M-31.06M-24.31M-20.60M-10.85M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/AN/AN/AN/AN/A
Other Investing Activity
0.000.000.00N/AN/A
INVESTING CASH FLOW
0.000.000.00N/AN/A
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
30.00M10.00M30.00MN/AN/A
Stock Issued/Repurchased
10.03M0.006.81M260.00K50.47M
Dividend Paid
N/AN/AN/A0.00-390.00K
FINANCING CASH FLOW
40.03M10.00M36.81M260.00K50.08M
 
CHANGE IN CASH
7.07M-21.06M12.50M-20.34M39.23M
 
FREE CASH FLOW
Operating Cash Flow
-32.97M-31.06M-24.31M-20.60M-10.85M
Capital Expenditure
N/AN/AN/AN/AN/A
FREE CASH FLOW
-32.97M-31.06M-24.31M-20.60M-10.85M

All data in USD

Charts